RLMD — Relmada Therapeutics, Inc. stock price, charts and financials

QT91Relmada Therapeutics, Inc.

Relmada Therapeutics, Inc. (NASDAQ: RLMD) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
4.54
-0.40-8.10%
OverviewShort InterestFilings
RLMDQT91Relmada Therapeutics, Inc.·NASDAQ
4.54-8.10%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 06, 20268-KCurrent report
Aug 06, 202610-QQuarterly report
Jul 29, 2026SC 13GBeneficial ownership statement (passive)
Jul 28, 20268-KCurrent report
Jun 22, 2026SC 13GBeneficial ownership statement (passive)
Jun 18, 2026S-8Registration of employee benefit securities
Jun 09, 2026SC 13GBeneficial ownership statement (passive)
May 28, 20268-KCurrent report
May 13, 2026S-3ASRS-3ASR
May 13, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 12, 20268-KCurrent report
May 12, 202610-QQuarterly report
May 04, 2026SC 13GBeneficial ownership statement (passive)
Apr 17, 2026DEFA14AAdditional proxy soliciting materials
Apr 17, 2026DEF 14ADefinitive proxy statement
Apr 09, 2026424B3Prospectus
Apr 09, 2026EFFECTNotice of effectiveness
Apr 06, 2026PRE 14APreliminary proxy statement
Apr 03, 2026S-3Shelf registration statement
Mar 20, 20268-KCurrent report
Mar 19, 202610-KAnnual report
Mar 09, 20268-KCurrent report
Feb 17, 2026SC 13GBeneficial ownership statement (passive)
Feb 17, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Feb 12, 2026SC 13GBeneficial ownership statement (passive)
#1 / 25 of 253
Page
▼
/ 11